日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation

对有截肢风险的晚期糖尿病足溃疡进行病灶内注射Citoprot-P(重组人表皮生长因子)

Fernández-Montequín, José I; Infante-Cristiá, Ena; Valenzuela-Silva, Carmen; Franco-Pérez, Neobalis; Savigne-Gutierrez, William; Artaza-Sanz, Heriberto; Morejón-Vega, Lourdes; González-Benavides, Cecilio; Eliseo-Musenden, Osvaldo; García-Iglesias, Elizeth; Berlanga-Acosta, Jorge; Silva-Rodríguez, Ricardo; Betancourt, Blas Y; López-Saura, Pedro A

Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds

表皮生长因子病灶内注射可以预防晚期糖尿病足伤口患者的截肢。

Acosta, Jorge Berlanga; Savigne, William; Valdez, Calixto; Franco, Neobalis; Alba, Jose S; del Rio, Amaurys; López-Saura, Pedro; Guillén, Gerardo; Lopez, Ernesto; Herrera, Luís; Férnandez-Montequín, José